5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis [PDF]
The Korean Journal of Gastroenterology, 2022 5-aminosalicylic acid (5-ASA) is used widely to treat ulcerative colitis. The common side effects of 5-ASA include nausea, vomiting, abdominal pain, headache, and skin rash.
Hyo Yeop Song, Geom Seog Seo
doaj +2 more sources
Prospective Questionnaire Survey on Adherence to Oral 5‐Aminosalicylic Acid in Patients With Ulcerative Colitis [PDF]
JGH OpenBackground Adherence to 5‐aminosalicylic acid (5‐ASA), an anchor drug for ulcerative colitis (UC), affects remission maintenance. This study aimed to investigate the current status of adherence to 5‐ASA and identify the factors associated with adherence.
Tsuyoshi Beppu +9 more
doaj +2 more sources
Perimyocarditis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid [PDF]
The Korean Journal of Gastroenterology5-Aminosalicylic acid (5-ASA) is recommended for managing ulcerative colitis. Common adverse effects associated with 5-ASA include gastrointestinal disorders, headaches, and skin rashes.
Hye Young Lee, Dong Hoon Baek
doaj +2 more sources
5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats [PDF]
PharmaceuticsBackground: 5-Aminosalicylic acid (5-ASA), the first-line therapy for ulcerative colitis, is a poorly soluble zwitterionic drug. Unformulated 5-ASA is thought to be extensively absorbed in the small intestine.
Yorinobu Maeda +7 more
doaj +2 more sources
Journal of Lipid Research, 1998 5-Aminosalicylic acid conjugate of ursodeoxycholic acid was synthesized in above 90% yield by adding a basic solution of 5-aminosalicylic acid into the mixed anhydride formed with ursodeoxycholic acid and ethyl chloroformate.
Ashok K. Batta +4 more
doaj +3 more sources
Association of Proton Pump Inhibitor and Potassium‐Competitive Acid Blocker Use With Discontinuation and Intolerance of Oral 5‐Aminosalicylic Acid in Patients With Ulcerative Colitis [PDF]
JGH OpenAims Proton pump inhibitors (PPIs) and potassium‐competitive acid blockers (PCABs) are widely used for acid‐related disorders. Recent studies have raised concerns that acid suppression may alter gut microbiota and drug pharmacokinetics, potentially ...
Shinsuke Otagiri +4 more
doaj +2 more sources
Current status of 5-aminosalicylic acid in Crohn’s disease treatment: a nationwide survey and analysis of perspectives and practice patterns among inflammatory bowel disease physicians [PDF]
Frontiers in GastroenterologyObjectiveTo investigate the perspectives and clinical practice patterns of inflammatory bowel disease (IBD) physicians regarding the use of 5-aminosalicylic acid (5-ASA) in Crohn’s disease (CD).MethodsA 21-item questionnaire was distributed to IBD ...
Yuanli Li, Changxin Chen, Chengdang Wang
doaj +2 more sources
5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis [PDF]
Nature CommunicationsOsteoarthritis (OA) is a progressive and irreversible degenerative joint disease that is characterized by cartilage destruction, osteophyte formation, subchondral bone remodeling, and synovitis.
Jihee Kim +14 more
doaj +2 more sources
Electroanalytical Overview: The Sensing of Mesalamine (5-Aminosalicylic Acid) [PDF]
ACS Measurement Science Au, 2023 Robert D. Crapnell +2 more
doaj +2 more sources
Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy [PDF]
DiseasesDiabetic wounds (DWs) are considered chronic complications observed in patients suffering from type 2 diabetes mellitus (DM). Usually, DWs originate from the interplay of inflammation, oxidation, impaired tissue re-epithelialization, vasculopathy ...
Bharat Kumar Reddy Sanapalli +3 more
doaj +2 more sources